Cargando…
Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity
The anti-parasitic benzimidazole flubendazole has been used for many years to treat intestinal infections in humans and animals. Previous genotoxicity studies have shown that the compound is not a bacterial mutagen and a bone marrow micronucleus test, using a formulation that limited systemic absorp...
Autores principales: | Tweats, David J., Johnson, George E., Scandale, Ivan, Whitwell, James, Evans, Dean B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840262/ https://www.ncbi.nlm.nih.gov/pubmed/26443851 http://dx.doi.org/10.1093/mutage/gev070 |
Ejemplares similares
-
Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity
por: Tweats, David J, et al.
Publicado: (2018) -
In vivo Mammalian Alkaline Comet Assay: Method Adapted for Genotoxicity Assessment of Nanomaterials
por: Cardoso, Renato, et al.
Publicado: (2022) -
Integration of In Vivo Genotoxicity and Short-term Carcinogenicity Assays Using F344 gpt Delta Transgenic Rats: In Vivo Mutagenicity of 2,4-Diaminotoluene and 2,6-Diaminotoluene Structural Isomers
por: Toyoda-Hokaiwado, Naomi, et al.
Publicado: (2010) -
Common Considerations for Genotoxicity Assessment of Nanomaterials
por: Elespuru, Rosalie K., et al.
Publicado: (2022) -
Threshold of Toxicological Concern—An Update for Non-Genotoxic Carcinogens
por: Batke, Monika, et al.
Publicado: (2021)